Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $8.4300 (4.2%) ($8.4300 - $8.4300) on Thu. Mar. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.03% (three month average) | RSI | 53 | Latest Price | $8.4300(4.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.5% a day on average for past five trading days. | Weekly Trend | CGEN advances 0.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(71%) ARKG(69%) ARKK(65%) IWO(64%) IBB(62%) | Factors Impacting CGEN price | CGEN will decline at least -2.515% in a week (0% probabilities). VIXM(-44%) VXX(-38%) UUP(-19%) IGOV(-13%) TLT(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.515% (StdDev 5.03%) | Hourly BBV | 0.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.8 | 5 Day Moving Average | $8.64(-2.43%) | 10 Day Moving Average | $8.81(-4.31%) | 20 Day Moving Average | $8.8(-4.2%) | To recent high | -39% | To recent low | 10.6% | Market Cap | $697m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |